purdue pharma

• Family owners of OxyContin maker Purdue Pharma to help pay out opioid lawsuits

  The company's bankruptcy plan will require the company's Sackler family owners to contribute nearly $4.3 billion to the settlement of nearly 3,000 lawsuits.

  Health

  Mar 16, 2021
  
• Lawyers in Canadian opioid class action hope U.S. guilty pleas bolster their case

  The upcoming hearing in Quebec comes after this week's news that Purdue Pharma, the company behind OxyContin, will plead guilty to federal criminal charges in the U.S.

  Canada

  Oct 22, 2020
  
• Advertisement
• Manitoba government plans to join class-action suit against opioid makers

  The suit, launched in August 2018, names more than 40 manufacturers, wholesalers and distributors of opioids in Canada.

  Health

  Oct 1, 2020
• Advertisement
• Mundipharma allegedly using fake doctors, misleading claims to drive OxyContin sales in China

  Another company owned by the Sackler family - makers of OxyContin - has used misleading claims and drug reps dressed up as doctors to peddle its signature painkiller in China

  World

  Nov 20, 2019
• Opioid crisis lawsuit sees drugmakers, distributors reach $260M settlement

  There are still more than 2,600 other lawsuits seeking to hold the drug industry accountable for an opioid crisis that has been linked to more than 400,000 deaths in the U.S. alone since 2000.

  World

  Oct 21, 2019
• Purdue Pharma, maker of OxyContin, to stay in business despite bankruptcy file

  Purdue lawyers secured permission for the multibillion-dollar company based in Stamford, Connecticut, to maintain business as usual -- paying employees and vendors, supplying pills to distributors, and keeping current on taxes and insurance.

  World

  Sep 17, 2019
• U.S. settlement won’t end B.C. lawsuit against Purdue Pharma, says province’s attorney general

  David Eby said if the deal isn't expanded to include Canadian claims, the province will press ahead with its legal action.

  Sep 16, 2019
• Purdue Pharma, maker of opioid painkiller OxyContin, files for bankruptcy

  The filing was anticipated before and after the tentative deal, which could be worth up to US$12 billion over time, was struck.

  World

  Sep 15, 2019
• Advertisement
• Family behind OxyContin secretly wired $1 billion to themselves, New York finds

  New York said it has uncovered the previously unknown wire transfers among family members, entities they control and several financial institutions.

  World

  Sep 13, 2019
• Advertisement
• Purdue Pharma in discussion to offer up to $12B to settle opioid claims: sources

  Purdue is among several drugmakers and distributors that are facing lawsuits, seeking to hold them responsible for fuelling the U.S. opioid addiction crisis.

  World

  Aug 27, 2019